Searle & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Searle & Co's GILD Position: Q3 2026 in Review
Searle & Co held its Gilead Sciences (GILD) position steady in Q3 2026 at 2,050 shares worth $306K. The position accounts for 0.07% of the portfolio, ranked #156.
Searle & Co first reported a position in GILD in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.68M in Q2 2015. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Searle & Co held 2,050 shares of Gilead Sciences worth $306K as of Q3 2026.
- Searle & Co left its Gilead Sciences share count unchanged in Q3 2026.
- Gilead Sciences made up 0.07% of Searle & Co's portfolio in Q3 2026, its #156 holding.
- Searle & Co first reported a position in Gilead Sciences in Q4 2014 and has held it in 25 quarters since.
- Searle & Co's Gilead Sciences position peaked at $1.68M in Q2 2015.
- 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Searle & Co's 13F filing for Q3 2026, filed 4 Nov 2026.